Humans go through a mini-puberty period that begins in fetal life and this continues in the newborn period and until middle infancy. The period when gender hormone levels are high, such as puberty (1). The hypothalamus-pituitary-gonadal axis is transiently activated during the first months of postnatal life (2). Kisspeptin is a very powerful neuropeptide that stimulates release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the pituitary and LH exhibits its effect via gonadotropin-releasing hormone [GnRH] (3). Kisspeptin is regarded as the major regulator of reproductive functions and onset of puberty (4, 5) by its direct action on gonadotrophs or through GnRH neurons (6, 7).The purpose of this study was to determine kisspeptin levels in healthy newborns and to show whether there is significant difference between kisspeptin levels in females and males hypothyroid newborns and healthy term newborns.
RESUMEN

Objetivo: El propósito de este estudio fue determinar los niveles de kisspeptina en recién nacidos sanos y mostrar si hay diferencia significativa en los niveles de kisspeptina entre machos y hembras en los recién nacidos hipotiroideos y los recién nacidos a término sanos.
Sujetos y métodos: Este estudio fue realizado de manera prospectiva. Los recién nacidos fueron admitidos en el Policlínico de Neonatología y Endocrinología Pediátrica del Hospital de Investigación de la Facultad de Medicina de la Universidad de Erzurum Atatürk entre julio y noviembre de 2014. En recién nacidos hipotiroideos, la muestra de sangre fue realizada 14−30 días después del nacimiento. Se incluyeron doce recién nacidos hipotiroideos, 14 recién nacidos prematuros y 36 recién nacidos a término (como grupo de control). Las muestras de plasma fueron investigadas usando el ensayo inmunoenzimá
INTRODUCTION
Humans go through a mini-puberty period that begins in fetal life and this continues in the newborn period and until middle infancy. The period when gender hormone levels are high, such as puberty (1) . The hypothalamus-pituitary-gonadal axis is transiently activated during the first months of postnatal life (2) . Kisspeptin is a very powerful neuropeptide that stimulates release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the pituitary and LH exhibits its effect via gonadotropin-releasing hormone [GnRH] (3). Kisspeptin is regarded as the major regulator of reproductive functions and onset of puberty (4, 5) by its direct action on gonadotrophs or through GnRH neurons (6, 7) .The purpose of this study was to determine kisspeptin levels in healthy newborns and to show whether there is significant difference between kisspeptin levels in females and males hypothyroid newborns and healthy term newborns.
SUBJECTS AND METHODS
This study was performed prospectively. The newborns admitted to the Erzurum Atatürk University Medical Faculty Research Hospital Pediatric Endocrinology and Neonatal polyclinic between July and November 2014. Blood sampling in hypothyroid newborns was performed in hypothyroid newborns 14−30 days after birth. Twelve hypothyroid newborns (7 females and 5 males), 14 premature newborns (8 females and 6 males) and 36 newborns (15 females and 21 males) as the control group were included. The newborns with any disease or congenital anomaly and with chronic disease of the mothers were excluded. Follicle stimulating hormone (normal: male 0.16 -4.1 mIU/mL, female 0.24 -14.2 mIU/mL), LH (normal 0.02 -7.0 mIU/mL), free T4 (FT4) (normal 0.61−1.4 ng/dL) and thyroid stimulating hormone [TSH] (normal 0.6-7 µIU/mL) were investigated in the blood specimens. Once informed consent had been received, newborns' prenatal and postnatal histories were taken and physical examinations was performed by same paediatric endocrinologist. Two milliliters of blood collected using routine venous blood collection methods was placed into tubes containing K 2 EDTA. Blood samples were centrifuged and stored at -80°C. Plasma specimens were gradually thawed the day before they were investigated and homogenized by vortexing at room temperature. Plasma specimens were investigated using enzyme-immune assay (EIA) following the manufacturer's instructions at the Atatürk University Hospital Biochemistry Department. (KiSS-1 (112−121) Amide/Kisspeptin-10/Metastin (45−54) Amide (Human) EIA KIT, Phoenix Pharmaceuticals Inc). Kisspeptin levels were expressed as nanograms/milliliter.
Statistical analysis
The minimum, maximum and mean values with standard deviations were determined for the patient's bodyweight, length and postnatal age SSPE 20 for Windows was used for data analysis. The Kolmogorov-Smirnov test was used to determine whether newborns' kisspeptin values were normally distributed. Since cases' kisspeptin values were normally distributed, the independent-samples t-test was used. Spearman correlation analysis was performed between kisspeptin and other parameters. Significance was set at p < 0.01. The study was approved by our University Ethics Committee (Date 3.7.2014 Session: 7 Decision number: 1).
RESULTS
Patients' demographic and laboratory data are shown in Table  1 . The youngest baby in terms of gestational age at birth in our premature group was 35 weeks old and the oldest 37 weeks old; mean gestational age value was 36.36 ± 0.63. In the hypothyroid group, minimum kisspeptin level was 0.48 ng/mL, maximum value was 0.78 ng/mL, mean was 0.61 ± 0.08 ng/mL. In the premature group, minimum kisspeptin level was 0.27 ng/mL, maximum level was 0.97 ng/mL, mean was 0.64 ± 0.17 ng/mL. In the control group of healthy term newborns, minimum kisspeptin level was 0.25 ng/mL, maximum level was 0.99 ng/mL, mean was 0.49 ± 0.17 ng/mL. A statistical significance in kisspeptin levels was determined between the hypothyroid and the control groups (p = 0.004). There was also a significance in kisspeptin levels between the premature and the control groups (p = 0.01). Although a negative correlation was determined between kisspeptin and bodyweight (p = 0.005, r: -0.352), no correlation was determined with length (p = 0.052, r: -0. 
DISCUSSION
Kisspeptin is synthesized from the arcuate nucleus in the hypothalamus and neurons in the anteroventral periventricular nucleus (3). Parallel changes in GnRH pulses also accompany an increase in kisspeptins, and an association has been shown between an increase in kisspeptin and pubertal changes in GnRH pulses. Central or peripheral administration of kisspeptin in an animal model has been shown to stimulate the hypothalamus-pituitary-gonadal axis and to increase secretion of FSH and LH (3, 8, 9) . Kisspeptins in the peripheral circulation function by passing the blood-brain barrier and affecting GnRH release (4) . Observations show that kisspeptins in the circulation are physiologically significant and play a role in the regulation of the hypothalamus-pituitary-gonadal axis in many species, including humans (10). Postnatal hypothalamus pituitary gonadal axis activation in infancy is increased in premature boys compared with healthy boys (11) . Kisspeptin may mediate this situation. Kisspeptin levels were significantly higher in premature and hypothyroid newborns compared to healthy newborns may be due to kisspeptin increasing release of FSH and LH by increasing the hormone GnRH. In our study, FSH levels were higher in the hypothyroid and premature newborns than in the control group. Luteinizing hormone levels were higher in the premature group compared to the control group, while LH levels were only low in the hypothyroid group. Low LH in hypothyroid conditions has also been confirmed in previous studies. Webster et al and Anderson et al both emphasized that thyroid hormones are necessary for GnRH and LH pulsatility (12, 13) . Other studies show that action of thyroid hormone on GnRH neurons as co-expression of thyroid hormone receptors in GnRH neurons has been previously demonstrated by Parhar et al and Jansen et al (14, 15) . Ogawa et al (16) have made the most comprehensive study that showing the relationship between kisspeptin and hypothyroidism. In the literature, it is the only study showing the relationship between kisspeptin and thyroid hormones. Their study shows that GnRH1 may be directly regulated through thyroid hormone, while the regulation of kiss2 by triiodothyronine is more likely to be indirect. They cloned kiss2 gene in a fish race. They showed that real-time polymerase chain reaction revealed that administration of triiodothyronine significantly increased the amount of kiss2 and gnrh1 mRNA levels 24 hours after administration when compared with control fish, while the genes were suppressed under hypothyroid condition with methimazole treatment (16) .
Kisspeptin levels were 0.64 ± 0.17 ng/mL in premature newborns, 0.61 ± 0.08 ng/mL in hypothyroid newborns and 0.49 ± 0.17 ng/mL in healthy newborns. Different studies have reported plasma kisspeptin levels of 2.96 ± 1.21 ng/dL in girls aged 3−8 years (17), 1.68 ± 0.95 ng/mL in children aged 5−9 years (18), 0.77 ng/mL in males aged 9−18 years and 6.24 ± 2.042 ng/mL in adults aged 18−40 years (19) , higher than the levels determined in our study. This may be due to our patients being in the newborn period. In addition, this finding shows that kisspeptin is at lower levels in the newborn period and increases with age.
One study reported no significant correlation between kisspeptin and anthropometric parameters [length and weight] (18). In our study, however, a weak negative correlation was determined between kisspeptin levels and bodyweight. This is the first study which investigates kisspeptin levels in hypothyoridic, premature and healthy newborns. In conclusion, statistically significant kisspeptin levels are determined between the hypothyroid and the control groups and also statistically significant kisspeptin levels were found between the premature and the control groups.
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